Sign In
Buy REPH
$0.675
+0 (+0%)
At Close: Aug 17, 2022
Recro To Report Financial Results for Second Quarter 2021 on August 9, 2021
04:05pm, Monday, 02'nd Aug 2021
Conference Call and Webcast Scheduled for Monday, August 9, 2021 at 4:30 p.m. Eastern Conference Call and Webcast Scheduled for Monday, August 9, 2021 at 4:30 p.m. Eastern
Recro Appoints Laura L. Parks, Ph.D.
07:00am, Wednesday, 16'th Jun 2021
Experienced Biopharma Executive with Track Record of Driving Commercial and Operational Success at Global CDMOs Experienced Biopharma Executive with Track Record of Driving Commercial and Operational
Underwriters' Full Exercise of Option Brings Gross Proceeds to $34.5 Million
Recro Announces Proposed Public Offering of Common Stock
04:30pm, Tuesday, 11'th May 2021
EXTON, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manu
Recro Pharma, Inc. (REPH) CEO David Enloe on Q1 2021 Results - Earnings Call Transcript
01:55am, Sunday, 09'th May 2021
Recro Pharma, Inc. (REPH) CEO David Enloe on Q1 2021 Results - Earnings Call Transcript
Recro Reports First Quarter 2021 Financial Results
04:05pm, Thursday, 06'th May 2021
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue
Recro to Report Financial Results for First Quarter 2021 on May 6
04:05pm, Thursday, 29'th Apr 2021
Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern Time Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern Time
Recro Strengthens Business Development Team to Drive Customer Growth and Diversification
07:00am, Monday, 05'th Apr 2021
Six Recent Hires Provide Broader Coverage and Expanded Capabilities in the Areas of Sales and Marketing
Recro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020 Results - Earnings Call Transcript
11:48pm, Saturday, 27'th Feb 2021
Recro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020 Results - Earnings Call Transcript
Recro Reports Fourth Quarter and Year End 2020 Financial Results
07:00am, Friday, 26'th Feb 2021
Strengthened Industry-Centric Leadership
Recro to Report Fourth Quarter and Year-End 2020 Financial Results Earlier Than Previously Announced
04:05pm, Tuesday, 23'rd Feb 2021
Conference Call and Webcast Moved Up to 8:00 a.m. Eastern on Friday, February 26 Conference Call and Webcast Moved Up to 8:00 a.m. Eastern on Friday, February 26
Recro Announces Amendment to Athyrium Credit Facility
07:00am, Tuesday, 23'rd Feb 2021
Reductions in Debt Principal and Interest Rate Further Strengthen Balance Sheet, Support Ongoing Efforts to Best Position Company for Significant CDMO Business Growth Reductions in Debt Principal and
Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26
04:05pm, Friday, 19'th Feb 2021
Conference Call and Webcast Scheduled for Friday, February 26 at 4:30 p.m. Eastern Time Conference Call and Webcast Scheduled for Friday, February 26 at 4:30 p.m. Eastern Time
Recro Grants Inducement Award to New Chief Executive Officer
09:34pm, Friday, 18'th Dec 2020
MALVERN, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical service
The 7 Worst Performing Stocks of 2020
01:18pm, Wednesday, 16'th Dec 2020
Perhaps this year like no other has demonstrated the yin-yang effect of the market. While we've seen incredible winners, these companies represent the worst performing stocks of 2020.
